Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. [electronic resource]
Producer: 20171120Description: e172085 p. digitalISSN:- 2374-2445
- Aged
- Antineoplastic Agents, Immunological -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- analysis
- Breast Neoplasms -- drug therapy
- Clinical Trials, Phase III as Topic
- Disease-Free Survival
- Docetaxel
- Female
- Humans
- Kaplan-Meier Estimate
- Lapatinib
- Lymphocytes, Tumor-Infiltrating -- immunology
- Middle Aged
- Multicenter Studies as Topic
- Multivariate Analysis
- Neoplasm Metastasis
- Paclitaxel -- therapeutic use
- Patient Selection
- Predictive Value of Tests
- Proportional Hazards Models
- Prospective Studies
- Protein Kinase Inhibitors -- therapeutic use
- Quinazolines -- therapeutic use
- Randomized Controlled Trials as Topic
- Receptor, ErbB-2 -- analysis
- Retrospective Studies
- T-Lymphocytes, Cytotoxic -- immunology
- Taxoids -- therapeutic use
- Time Factors
- Trastuzumab -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.